AAAAAA

   
Results: 1-20 |
Results: 20

Authors: KOOPMANSCHAP MA
Citation: Ma. Koopmanschap, COST-OF-ILLNESS STUDIES - USEFUL FOR HEALTH-POLICY, PharmacoEconomics, 14(2), 1998, pp. 143-148

Authors: BROUWER WBF KOOPMANSCHAP MA
Citation: Wbf. Brouwer et Ma. Koopmanschap, HOW TO CALCULATE INDIRECT COSTS IN ECONOMIC EVALUATIONS, PharmacoEconomics, 13(5), 1998, pp. 563-566

Authors: MEERDING WJ BONNEUX L POLDER JJ KOOPMANSCHAP MA VANDERMAAS PJ
Citation: Wj. Meerding et al., DEMOGRAPHIC AND EPIDEMIOLOGIC DETERMINANTS OF HEALTH-CARE COSTS IN NETHERLANDS - COST OF ILLNESS STUDY, BMJ. British medical journal, 317(7151), 1998, pp. 111-115

Authors: BROUWER WBF KOOPMANSCHAP MA RUTTEN FFH
Citation: Wbf. Brouwer et al., PATIENT AND INFORMAL CAREGIVER TIME IN COST-EFFECTIVENESS ANALYSIS - A RESPONSE TO THE RECOMMENDATIONS OF THE WASHINGTON PANEL, International journal of technology assessment in health care, 14(3), 1998, pp. 505-513

Authors: VANENCKEVORT PJ TENVERGERT EM BONSEL GJ GEERTSMA A VANDERBIJ W DEBOER WJ KOOPMANSCHAP MA AL MJ RUTTEN FFH
Citation: Pj. Vanenckevort et al., TECHNOLOGY-ASSESSMENT OF THE DUTCH LUNG TRANSPLANTATION PROGRAM, International journal of technology assessment in health care, 14(2), 1998, pp. 344-356

Authors: AL MJ KOOPMANSCHAP MA VANENCKEVORT PJ GEERTSMA A VANDERBIJ W DEBOER WJ TENVERGERT EM
Citation: Mj. Al et al., COST-EFFECTIVENESS OF LUNG TRANSPLANTATION IN THE NETHERLANDS - A SCENARIO ANALYSIS, Chest, 113(1), 1998, pp. 124-130

Authors: VANENCKEVORT PJ KOOPMANSCHAP MA TENVERGERT EM GEERTSMA A VANDERBIJ W DEBOER WJ RUTTEN FFH
Citation: Pj. Vanenckevort et al., LIFETIME COSTS OF LUNG TRANSPLANTATION - ESTIMATION OF INCREMENTAL COSTS, Health economics, 6(5), 1997, pp. 479-489

Authors: BROUWER WBF KOOPMANSCHAP MA RUTTEN FFH
Citation: Wbf. Brouwer et al., PRODUCTIVITY COSTS IN COST-EFFECTIVENESS ANALYSIS - NUMERATOR OR DENOMINATOR - A FURTHER DISCUSSION, Health economics, 6(5), 1997, pp. 511-514

Authors: BROUWER WBF KOOPMANSCHAP MA RUTTEN FFH
Citation: Wbf. Brouwer et al., PRODUCTIVITY COSTS MEASUREMENT THROUGH QUALITY-OF-LIFE - A RESPONSE TO THE RECOMMENDATION OF THE WASHINGTON PANEL, Health economics, 6(3), 1997, pp. 253-259

Authors: KOOPMANSCHAP MA RUTTEN FFH VANINEVELD BM VANROIJEN L
Citation: Ma. Koopmanschap et al., THE FRICTION COST METHOD - REPLY, Journal of health economics, 16(2), 1997, pp. 257-259

Authors: KOOPMANSCHAP MA RUTTEN FFH
Citation: Ma. Koopmanschap et Ffh. Rutten, A PRACTICAL GUIDE FOR CALCULATING INDIRECT COSTS OF DISEASE, PharmacoEconomics, 10(5), 1996, pp. 460-466

Authors: VANROIJEN L ESSINKBOT ML KOOPMANSCHAP MA BONSEL G RUTTEN FFH
Citation: L. Vanroijen et al., LABOR AND HEALTH-STATUS IN ECONOMIC-EVALUATION OF HEALTH-CARE - THE HEALTH AND LABOR QUESTIONNAIRE, International journal of technology assessment in health care, 12(3), 1996, pp. 405-415

Authors: KOOPMANSCHAP MA RUTTEN FFH
Citation: Ma. Koopmanschap et Ffh. Rutten, INDIRECT COSTS - THE CONSEQUENCE OF PRODUCTION LOSS OR INCREASED COSTS OF PRODUCTION, Medical care, 34(12), 1996, pp. 59-68

Authors: VANROIJEN L ESSINKBOT ML KOOPMANSCHAP MA MICHEL BC RUTTEN FFH
Citation: L. Vanroijen et al., SOCIETAL PERSPECTIVE ON THE BURDEN OF MIGRAINE IN THE NETHERLANDS, PharmacoEconomics, 7(2), 1995, pp. 170-179

Authors: VANBALLEGOOIJEN M KOOPMANSCHAP MA HABBEMA JDF
Citation: M. Vanballegooijen et al., THE MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) - EXTENSIVENESS AND COSTS IN THE NETHERLANDS, European journal of cancer, 31A(10), 1995, pp. 1672-1676

Authors: VANROIJEN L KOOPMANSCHAP MA RUTTEN FFH VANDERMAAS PJ
Citation: L. Vanroijen et al., INDIRECT COSTS OF DISEASE - AN INTERNATIONAL COMPARISON, Health policy, 33(1), 1995, pp. 15-29

Authors: KOOPMANSCHAP MA RUTTEN FFH VANINEVELD BM VANROIJEN L
Citation: Ma. Koopmanschap et al., THE FRICTION COST METHOD FOR MEASURING INDIRECT COSTS OF DISEASE, Journal of health economics, 14(2), 1995, pp. 171-189

Authors: KOOPMANSCHAP MA RUTTEN FFH
Citation: Ma. Koopmanschap et Ffh. Rutten, THE IMPACT OF INDIRECT COSTS ON OUTCOMES OF HEALTH-CARE PROGRAMS, Health economics, 3(6), 1994, pp. 385-393

Authors: KOOPMANSCHAP MA VANROIJEN L BONNEUX L BARENDREGT JJ
Citation: Ma. Koopmanschap et al., CURRENT AND FUTURE COSTS OF CANCER, European journal of cancer, 30A(1), 1994, pp. 60-65

Authors: KOOPMANSCHAP MA RUTTEN FFH
Citation: Ma. Koopmanschap et Ffh. Rutten, INDIRECT COSTS IN ECONOMIC-STUDIES - CONFRONTING THE CONFUSION, PharmacoEconomics, 4(6), 1993, pp. 446-454
Risultati: 1-20 |